| Dr Sunil Dilipkumar Shroff, MD | |
|
800 Washington St, Box #311, Boston, MA 02111-1552 | |
| (617) 636-4721 | |
| Not Available |
| Full Name | Dr Sunil Dilipkumar Shroff |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 24 Years |
| Location | 800 Washington St, Boston, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164457875 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 215812 (Massachusetts) | Primary |
| 171W00000X | Contractor | A88238 (California) | Secondary |
| 207P00000X | Emergency Medicine | A88238 (California) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Tufts Medical Center | Boston, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Tufts Medical Center Ep Llc | 0446306716 | 13 |
News Archive
Medicare and Medicaid chief Donald Berwick will testify before a congressional committee Wednesday for the first time since President Barack Obama avoided the Senate confirmation process to Republican protest by using a recess appointment to install Berwick as the administrator of the Center for Medicare and Medicaid Services.
Dr. Fred Gage, a professor in the Salk Institute Laboratory of Genetics and holder of the Vi and John Adler Chair for Research on Age-Related Neurodegenerative Diseases, has been named a 2011 recipient of the prestigious National Institutes of Health (NIH) Director's Transformative Research Projects (T-R01) program.
Researchers scour what is known to come up with a hypothesis of why blood clots can be a major problem in COVID-19
The University of South Florida's Department of Neurosurgery and Brain Repair has been granted a patent for a cell transplantation procedure combining human umbilical cord blood cells and a sugar-alcohol compound called "mannitol" that may make a big difference in treating life-threatening neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, multiple sclerosis and stroke, among others.
Genentech, Inc., a wholly owned member of the Roche Group, today announced that it will present new data for its targeted cancer medicines and the way they may be used in several different cancer types at the 46th Annual Meeting of the American Society of Clinical Oncology (ASCO). Approximately 400 abstracts featuring Genentech and Roche's cancer medicines and investigational agents across 30 cancer types will be presented during the meeting that is taking place June 4 to 8, 2010 in Chicago.
› Verified 4 days ago
| Entity Name | Tufts Medical Center Ep Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609015262 PECOS PAC ID: 0446306716 Enrollment ID: O20090929000298 |
News Archive
Medicare and Medicaid chief Donald Berwick will testify before a congressional committee Wednesday for the first time since President Barack Obama avoided the Senate confirmation process to Republican protest by using a recess appointment to install Berwick as the administrator of the Center for Medicare and Medicaid Services.
Dr. Fred Gage, a professor in the Salk Institute Laboratory of Genetics and holder of the Vi and John Adler Chair for Research on Age-Related Neurodegenerative Diseases, has been named a 2011 recipient of the prestigious National Institutes of Health (NIH) Director's Transformative Research Projects (T-R01) program.
Researchers scour what is known to come up with a hypothesis of why blood clots can be a major problem in COVID-19
The University of South Florida's Department of Neurosurgery and Brain Repair has been granted a patent for a cell transplantation procedure combining human umbilical cord blood cells and a sugar-alcohol compound called "mannitol" that may make a big difference in treating life-threatening neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, multiple sclerosis and stroke, among others.
Genentech, Inc., a wholly owned member of the Roche Group, today announced that it will present new data for its targeted cancer medicines and the way they may be used in several different cancer types at the 46th Annual Meeting of the American Society of Clinical Oncology (ASCO). Approximately 400 abstracts featuring Genentech and Roche's cancer medicines and investigational agents across 30 cancer types will be presented during the meeting that is taking place June 4 to 8, 2010 in Chicago.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sunil Dilipkumar Shroff, MD 800 Washington St, Box #311, Boston, MA 02111-1552 Ph: (617) 636-4721 | Dr Sunil Dilipkumar Shroff, MD 800 Washington St, Box #311, Boston, MA 02111-1552 Ph: (617) 636-4721 |
News Archive
Medicare and Medicaid chief Donald Berwick will testify before a congressional committee Wednesday for the first time since President Barack Obama avoided the Senate confirmation process to Republican protest by using a recess appointment to install Berwick as the administrator of the Center for Medicare and Medicaid Services.
Dr. Fred Gage, a professor in the Salk Institute Laboratory of Genetics and holder of the Vi and John Adler Chair for Research on Age-Related Neurodegenerative Diseases, has been named a 2011 recipient of the prestigious National Institutes of Health (NIH) Director's Transformative Research Projects (T-R01) program.
Researchers scour what is known to come up with a hypothesis of why blood clots can be a major problem in COVID-19
The University of South Florida's Department of Neurosurgery and Brain Repair has been granted a patent for a cell transplantation procedure combining human umbilical cord blood cells and a sugar-alcohol compound called "mannitol" that may make a big difference in treating life-threatening neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, multiple sclerosis and stroke, among others.
Genentech, Inc., a wholly owned member of the Roche Group, today announced that it will present new data for its targeted cancer medicines and the way they may be used in several different cancer types at the 46th Annual Meeting of the American Society of Clinical Oncology (ASCO). Approximately 400 abstracts featuring Genentech and Roche's cancer medicines and investigational agents across 30 cancer types will be presented during the meeting that is taking place June 4 to 8, 2010 in Chicago.
› Verified 4 days ago
Yeu-shin Cindy Chang, M.D., M.P.H. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 75 Francis St, Bwh Dept. Of Emergency Medicine, Boston, MA 02115 Phone: 617-732-8070 | |
Lorenzo Albala, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 55 Fruit St, Boston, MA 02114 Phone: 617-724-4068 | |
Dr. Jacob Ari Hurwitz, MD MPH Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 55 Fruit St, Boston, MA 02114 Phone: 617-724-4068 | |
Christopher Lites, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 330 Brookline Ave, Boston, MA 02215 Phone: 617-667-7000 | |
Aneesh T Narang, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1 Boston Medical Ctr Pl, Dowling 1 South, Boston, MA 02118 Phone: 617-414-5481 Fax: 617-414-7759 | |
Dr. Justin Thomas Pitman, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 75 Francis St, Neville House - 236a, Boston, MA 02115 Phone: 617-732-8070 | |
Dr. Nadine Youssef, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 750 Washington St, Box 311 / Department Of Emergency Medicine, Boston, MA 02111 Phone: 617-636-4723 |